Longevity Technology: 'Juvenescence CEO on near-term Longevity breakthroughs
April 20, 2020
Dr. Bailey discusses Juvenescence’s plans to bring on a completely new mechanism for regeneration and how that plan is coming to life through its JuvRegeneration division – specifically through partners LyGenesis and AgeX Therapeutics.
He also discusses Juvenescence’s Q3 product launch of a direct-to-consumer ketone di-ester drink product that is geroprotective, neuroprotective and cardioprotective.
Read the full article at Longevity Technology.